Cargando…

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients

Production of de novo donor-specific antibodies (dnDSA) is a major risk factor for acute and chronic antibody-mediated rejection and graft loss after all solid organ transplantation. In this article, we review the data available on the risk of individual immunosuppressive agents and their ability to...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Leary, Jacqueline G., Samaniego, Millie, Barrio, Marta Crespo, Potena, Luciano, Zeevi, Adriana, Djamali, Arjang, Cozzi, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683034/ https://www.ncbi.nlm.nih.gov/pubmed/26680372 http://dx.doi.org/10.1097/TP.0000000000000869

Ejemplares similares

Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients
por: Hennes, Anthony J., et al.
Publicado: (2020)

The Clinical Impact of Anti-HLA Donor Specific Antibody Detection Through First Year Screening on Stable Kidney Transplant Recipients
por: Sharma, Akhil, et al.
Publicado: (2022)

Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation
por: Masset, Christophe, et al.
Publicado: (2022)

Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis
por: Bouquegneau, Antoine, et al.
Publicado: (2018)

Medium-term outcome of recipients of marginal donor hearts selected with new stress-echocardiographic techniques over standard criteria
por: Bombardini, Tonino, et al.
Publicado: (2014)

Kidney Transplant Recipients With Primary Membranous Glomerulonephritis Have a Higher Risk of Acute Rejection Compared With Other Primary Glomerulonephritides
por: Singh, Tripti, et al.
Publicado: (2017)

The care of kidney transplant recipients during a global pandemic: Challenges and strategies for success
por: Aziz, Fahad, et al.
Publicado: (2020)

Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis
por: Bouquegneau, Antoine, et al.
Publicado: (2018)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy
por: Panzer, Sarah E., et al.
Publicado: (2019)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018)

De Novo Cytomegalovirus Colitis in a Donor-Seronegative/Recipient-Seronegative Kidney Transplant Recipient
por: Sulaiman, Zoheb I, et al.
Publicado: (2023)

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2021)

Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2018)

Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2022)

HLA‐EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities
por: Geffard, Estelle, et al.
Publicado: (2021)

Early Report on Published Outcomes in Kidney Transplant Recipients Compared to Nontransplant Patients Infected With Coronavirus Disease 2019
por: Aziz, Fahad, et al.
Publicado: (2020)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
por: López del Moral, Covadonga, et al.
Publicado: (2022)

De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction?
por: Alberu, Josefina, et al.
Publicado: (2012)

De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients
por: Cioni, Michela, et al.
Publicado: (2017)

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
por: Baghai Arassi, Maral, et al.
Publicado: (2022)

Association between SARS-CoV-2 infection and de novo HLA donor specific antibody production in lung transplant recipients: Single-center study
por: Shah, Sadia Z., et al.
Publicado: (2022)

Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes
por: Gniewkiewicz, Michal, et al.
Publicado: (2023)

Covid-19 in recipients of heart and lung transplantation: Learning from experience
por: Kittleson, Michelle M., et al.
Publicado: (2021)

Influence of Donors’ and Recipients’ HLA Typing on Renal Function Immediately After Kidney Transplantation
por: Rostami, Zohreh, et al.
Publicado: (2013)

Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential
por: Mallon, Dermot H., et al.
Publicado: (2018)

Donor–Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms
por: Jethwani, Priyanka, et al.
Publicado: (2022)

Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART
por: Potena, Luciano, et al.
Publicado: (2018)

Multiscale genetic architecture of donor-recipient differences reveals intronic LIMS1 mismatches associated with kidney transplant survival
por: Sun, Zeguo, et al.
Publicado: (2023)

Histopathological characteristics and causes of kidney graft failure in the current era of immunosuppression
por: Parajuli, Sandesh, et al.
Publicado: (2019)

An Analysis by the European Committee on Organ Transplantation of the Council of Europe Outlining the International Landscape of Donors and Recipients Sex in Solid Organ Transplantation
por: Cozzi, Emanuele, et al.
Publicado: (2022)

Association Between Severe SARS-CoV-2 Infection and De Novo HLA Donor Specific Antibody Production in Lung Transplant Recipients: Single-center study
por: Shah, Sadia, et al.
Publicado: (2023)

Donor HLA−DR Drives the Development of De Novo Autoimmunity Following Lung and Heart Transplantation
por: Jankowska−Gan, Ewa, et al.
Publicado: (2020)

Continuation of Peritoneal Dialysis in Adult Kidney Transplant Recipients With Delayed Graft Function
por: Gardezi, Ali I., et al.
Publicado: (2021)

Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes
por: Garg, Neetika, et al.
Publicado: (2018)

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients
por: Merli, Marco, et al.
Publicado: (2021)

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
por: de Sousa, Marcos Vinicius, et al.
Publicado: (2018)

Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum
por: Won, Dong Il, et al.
Publicado: (2020)

Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target
por: Vidyasagar, Aparna, et al.
Publicado: (2012)

The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis
por: Danobeitia, Juan S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e0dp3q58jhdrbvns75mojla2fg